Companies › ZSQR
COEPTIS THERAPEUTICS HLDGS I (ZSQR)
Institutional ownership, SEC filings and insider activity
Sector: Financials · SEC CIK 0001759186 · EDGAR filings · Updated 2026-07-27
COEPTIS THERAPEUTICS HLDGS I (ZSQR) has reported institutional ownership of 0.4%, with 12 institutional managers holding positions valued at $5.36M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.
Filings this week (2)
- 2026-07-27 — POSASR filed
- 2026-07-22 — Current report (8-K) filed
Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.
Latest updates
- 2026-07-10 — Current report (8-K) filed
- 2026-07-07 — Current report (8-K) filed
- 2026-07-07 — Initial insider ownership filed (Form 3)
- 2026-07-07 — S-3ASR filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, COEPTIS THERAPEUTICS HLDGS I has 12 institutional holders and institutional ownership of 0.4%.
Insider activity
Insiders reported 18 transactions (0 buys, 0 sells) across 9 reporting insiders, with a net reported value of $0.
Data flags from SEC filings
Related companies
21SHARES ETHEREUM ETF (TETH) · 21SHARES XRP ETF (TOXR) · SIEBERT FINL CORP (SIEB) · Fold Holdings Inc. (FLD) · Aurelion Inc. (AURE) · DOMINARI HOLDINGS (DOMH)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-27.